Design and Synthesis of Novel Pyridoxine 5‘-Phosphonates as Potential Antiischemic Agents
Citations Over TimeTop 23% of 2003 papers
Abstract
On the basis of previous reports that the natural cofactor pyridoxal 5'-phosphate 1 appears to display cardioprotective properties, a series of novel mimetics of this cofactor were envisioned. As pyridoxal 5'-phosphate is a natural compound and is subject to biological degradation and elimination pathways, the objective was to generate active phosphonates that are potentially less light sensitive and more stable in vivo than the parent vitamer. Several phosphonates were designed and synthesized, and in particular, compounds 10 and 14 displayed similar biological traits to natural phosphate 1 in the rat model of regional myocardial ischemia and reperfusion. A reduction in infarct size was observed in animals treated with these compounds. In an effort to identify other relevant cardioprotective models in order to potentially define structure-activity relationships, these three compounds were tested in the rat working heart model. Compounds 1, 10, and 14 were compared to dichloroacetic acid (DCA) as positive control in this model. As with DCA, compounds 1, 10, and 14 were found to induce a shift from fatty acid oxidation toward glucose oxidation.
Related Papers
- → Plasma binding of vitamin B6 compounds(1974)78 cited
- → Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism.(1980)104 cited
- → Effect of Vitamin B6 Depletion on the Pyridoxal, Pyridoxamine and Pyridoxine Content of the Blood and Urine of Men(1968)50 cited
- → Transport and metabolism of pyridoxine and pyridoxal in mice.(1987)15 cited
- → Vitamin B6 in Foodstuffs: HPLC Method(1985)4 cited